BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2702147)

  • 1. Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranes.
    Schindler R; Lonnemann G; Shaldon S; Koch KM; Dinarello CA
    Contrib Nephrol; 1989; 74():58-65. PubMed ID: 2702147
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production.
    Herbelin A; Ureña P; Man NK; Drüeke T; Descamps-Latscha B
    Contrib Nephrol; 1989; 74():79-85. PubMed ID: 2702150
    [No Abstract]   [Full Text] [Related]  

  • 3. Phagocytic activity of leukocytes induced by different dialyzer membranes.
    Vanholder R; Dhondt A; Van Landschoot N; Waterloos MA; Ringoir S
    Contrib Nephrol; 1989; 74():86-90. PubMed ID: 2518453
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. I. Radiolabeled endotoxin.
    Ureña P; Herbelin A; Basile C; Zingraff J; Man NK; Drüeke T
    Contrib Nephrol; 1989; 74():71-8. PubMed ID: 2702149
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS).
    Laude-Sharp M; Caroff M; Simard L; Pusineri C; Kazatchkine MD; Haeffner-Cavaillon N
    Kidney Int; 1990 Dec; 38(6):1089-94. PubMed ID: 2127434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of tumor necrosis factor in hemodiafiltration].
    Tetta C; Segoloni G; Fidelio T; Licata C; Sancipriano GP; Iacono G; Ragni R; Vercellone A
    Minerva Urol Nefrol; 1991; 43(3):181-3. PubMed ID: 1817342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of cytokines in hemodialysis.
    Tetta C; Camussi G; Turello E; Salomone M; Aimo G; Priolo G; Segoloni G; Vercellone A
    Blood Purif; 1990; 8(6):337-46. PubMed ID: 2093331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of dialysis membranes on interleukin-1 beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells.
    Higuchi T; Kuno T; Takahashi S; Kanmatsuse K
    Artif Organs; 1997 Apr; 21(4):265-71. PubMed ID: 9096797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cytokines by dialysis membranes in normal whole blood: a new in vitro assay for evaluating membrane biocompatibility.
    Herbelin A; Nguyen AT; Urena P; Descamps-Latscha B
    Blood Purif; 1992; 10(1):40-52. PubMed ID: 1389011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of acute leukopenia in hemodialysis. Role of direct leukocyte and dialyzer membrane interaction].
    Pacitti A; Segoloni G; Triolo G; Tetta C; Messina M; Bussolino F; Camussi G; Ragni R; Martini PF; Coppo R; Vercellone A
    Minerva Nefrol; 1980; 27(4):651-3. PubMed ID: 7254693
    [No Abstract]   [Full Text] [Related]  

  • 11. [Levels of tumor necrosis factor and interleukin 1 in uremia and in hemodialysis].
    Peona C; Fortina A; Colombo P; Filiberti O; Cagna G; Costantini L; Porcu M
    Minerva Urol Nefrol; 1991; 43(3):175-9. PubMed ID: 1726274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination.
    Bigazzi R; Atti M; Baldari G
    Blood Purif; 1990; 8(4):190-8. PubMed ID: 2085427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms and consequences of complement activation during hemodialysis.
    Kazatchkine MD; Haeffner-Cavaillon N
    Adv Exp Med Biol; 1989; 260():19-26. PubMed ID: 2624243
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes.
    Lonnemann G; Schindler R; Lufft V; Mahiout A; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1995; 10(2):207-11. PubMed ID: 7753454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis.
    Canivet E; Lavaud S; Wong T; Guenounou M; Willemin JC; Potron G; Chanard J
    Am J Kidney Dis; 1994 Jan; 23(1):41-6. PubMed ID: 8285196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behaviour of clearances and diffusive permeability during hemodialysis with PMMA dialyzers: clinical study.
    Ghezzi PM; Canepari G; Ronco C
    Contrib Nephrol; 1999; 125():53-64. PubMed ID: 9895430
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes.
    Campistol JM; Torregrosa JV; Ponz E; Fenollosa B
    Contrib Nephrol; 1999; 125():76-85. PubMed ID: 9895432
    [No Abstract]   [Full Text] [Related]  

  • 18. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
    Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
    Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of leukocytes eluted from haemodialysers.
    Castiglione A; Pagliaro P; Romagnoni M; Beccari M; Cavaliere G; Veneroni G; Sorgato G
    Nephrol Dial Transplant; 1991; 6 Suppl 2():31-5. PubMed ID: 1866065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hemodialysis membranes on gene expression and plasma levels of interleukin-1 beta.
    Qian J; Yu Z; Dai H; Zhang Q; Chen S
    Artif Organs; 1995 Aug; 19(8):842-6. PubMed ID: 8573006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.